Intervet/Schering-Plough Animal Health is reintroducing to the U.S. market the Vista vaccine line, which provides dairy veterinarians and producers with the most complete protection available against the most common and costly bovine respiratory and reproductive diseases.

Vista vaccines protect dairy cattle against Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD Type 1 and Type 2), Parainfluenza3 (PI3), Bovine Respiratory Syncytial Virus (BRSV), leptospirosis, vibriosis, Mannheimia haemolytica and Pasteurella multocida.

The Vista line of vaccines was introduced to the market in 2005 with more research supporting its safety and efficacy than any other cattle vaccine at the time. A stop sale was issued on the vaccine in 2009 due to a variability issue with the BRSV antigen. Intervet/Schering-Plough Animal Health worked with the U.S. Department of Agriculture to resolve the issue and is pleased to welcome back this cattle vaccine to its portfolio and the market with even more research that confirms its superior respiratory and reproductive disease protection.

Vista vaccines are available through veterinarians and animal-health suppliers. Producers are encouraged to work with their veterinarians to design a vaccination-management program appropriate for their herds. PD

—From Intervet/Schering-Plough Animal Health news release